Stada cuts loan size and tightens pricing ahead of commitment deadline

Stada, the German pharmaceutical firm, has shrunk its leveraged loan by €250m and increased its high yield bond by the same amount, ahead of the loan's commitment deadline on Thursday.

  • By Bianca Boorer
  • 21 Sep 2017

The seven year term loan was initially intended to be for €1.95bn and the bond for €875m (see corporate bond section for more on the bond).

“The bond was multiple times subscribed [due to] strong demand there,” said a banker on the deal. "[It’s] not a sign of ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 27,131.20 86 8.51%
2 BNP Paribas 21,328.50 125 6.69%
3 Goldman Sachs 16,485.11 67 5.17%
4 Deutsche Bank 15,107.77 87 4.74%
5 HSBC 14,990.50 96 4.70%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 8,469.76 69 8.01%
2 Goldman Sachs 8,116.84 64 7.68%
3 Credit Suisse 6,908.88 70 6.54%
4 Deutsche Bank 6,384.59 62 6.04%
5 BNP Paribas 5,941.97 66 5.62%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 37,132.38 289 10.76%
2 Citi 28,905.88 231 8.38%
3 Bank of America Merrill Lynch 28,846.52 251 8.36%
4 Goldman Sachs 24,953.24 183 7.23%
5 Barclays 23,148.60 155 6.71%